X4 Pharmaceuticals (XFOR) Change in Accured Expenses (2017 - 2025)

X4 Pharmaceuticals' Change in Accured Expenses history runs 9 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• Quarterly Change in Accured Expenses fell 35.12% year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.0 million (down 128.25% YoY) and the FY2025 annual result came in at -$2.0 million, down 128.25% from the prior year.
• Change in Accured Expenses was $2.2 million for Q4 2025 at X4 Pharmaceuticals, down from $3.4 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $4.5 million in Q2 2023 and bottomed at -$7.8 million in Q1 2025.
• A 5-year average of $520150.0 and a median of $640500.0 in 2022 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 2540.3% — and 2025, when it plunged 715.66%.
• X4 Pharmaceuticals' Change in Accured Expenses stood at -$1.2 million in 2021, then surged by 304.59% to $2.5 million in 2022, then slumped by 261.85% to -$4.0 million in 2023, then soared by 182.54% to $3.3 million in 2024, then plunged by 35.12% to $2.2 million in 2025.
• Business Quant data shows XFOR's Change in Accured Expenses at $2.2 million in Q4 2025, $3.4 million in Q3 2025, and $227000.0 in Q2 2025.